Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Wastewater testing during the South African 2022-2023 measles outbreak demonstrates the potential of environmental surveillance to support measles elimination

Nkosenhle Ndlovu, View ORCID ProfileVictor Mabasa, View ORCID ProfileChenoa Sankar, View ORCID ProfileNosihle Msomi, View ORCID ProfileEmmanuel Phalane, View ORCID ProfileNatasha Singh, View ORCID ProfileSipho Gwala, View ORCID ProfileFiona Els, View ORCID ProfileMokgaetji Macheke, View ORCID ProfileSibonginkosi Maposa, View ORCID ProfileMukhlid Yousif, View ORCID ProfileKerrigan M. McCarthy
doi: https://doi.org/10.1101/2024.09.01.24312904
Nkosenhle Ndlovu
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Victor Mabasa
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Victor Mabasa
Chenoa Sankar
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chenoa Sankar
Nosihle Msomi
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nosihle Msomi
Emmanuel Phalane
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emmanuel Phalane
Natasha Singh
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natasha Singh
Sipho Gwala
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sipho Gwala
Fiona Els
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
2Gauteng City-Region Observatory (GCRO), Gauteng, South Africa,
4School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fiona Els
Mokgaetji Macheke
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mokgaetji Macheke
Sibonginkosi Maposa
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sibonginkosi Maposa
Mukhlid Yousif
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
3Department of Virology, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mukhlid Yousif
Kerrigan M. McCarthy
1Wastewater Genomics, Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, Gauteng, South Africa,
3Department of Virology, School of Pathology, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng, South Africa
4School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, Gauteng, South Africa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kerrigan M. McCarthy
  • For correspondence: kerriganm{at}nicd.ac.za
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Sensitive clinical surveillance and high vaccination coverage are required to meet the WHO 2030 measles elimination target. Whilst wastewater and environmental surveillance (WES) has proven usefulness in polio surveillance, it has not been applied to measles control. We describe the development of digital RT-PCR (RT-dPCR) for detection and quantification of measles virus (MeV) in wastewater, and application to retained concentrated samples obtained from 28 national sentinel SARS-CoV-2 wastewater surveillance sites and 19 localised collection points in a single province before, during and after a measles outbreak of over 2,000 laboratory-confirmed cases.

Methods We validated a RT-dPCR assay incorporating WHO-recommended primers for detection and differentiation of wild-type and vaccine genotypes. We applied this to retained wastewater samples concentrated by ultrafiltration and stored at −20°C. We compared wastewater findings by district and epidemiological weeks with laboratory-confirmed measles case data obtained from national fever-rash surveillance for districts with adequate surveillance indicators (>2/100,000 non-measles cases)

Findings Amongst 2,149 wastewater concentrates obtained between 16 February 2021 and 08 March 2024, we identified 43 (2%) samples containing MeV RNA in concentrations ranging from 2,04-6,11 genome copies/mL. MeV genotype A (vaccine strain) was co-detected in wastewater in 6 instances along with non-A (wild-type) genotypes. Comparison of wastewater and clinical fever-rash surveillance data by epidemiological week and district identified 27 district-time instances where at least one positive wastewater sample was identified, of which 14 (52%) districts reported at least one laboratory-confirmed clinical case in that same epidemiological week. Amongst districts with positive wastewater samples, wastewater surveillance detected MeV in 13/27 (48%) time-district pairs when clinical surveillance failed to detect cases. Amongst district-time instances where at least one laboratory-confirmed measles case was detected (N=127), MeV was detected in at least one wastewater sample collected in that same epidemiological week in 14 (11%) districts

Interpretation Wastewater surveillance may be a useful complementary surveillance tool for identification of districts with ongoing measles circulation. MeV detection rates may be improved by real-time testing to limit RNA degradation and improved concentration and nucleic acid extraction processes. Ongoing wastewater surveillance for MeV should be conducted in order to understand the role of WES in measles control and elimination.

Funding This work was funded by BMGF (INV-049271)

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Yes

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol for this study was reviewed and approved by the University of the Witwatersrand Human Research Ethics Committee (MM220904). Clinical data were analysed anonymously

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Not Applicable

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 02, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Wastewater testing during the South African 2022-2023 measles outbreak demonstrates the potential of environmental surveillance to support measles elimination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Wastewater testing during the South African 2022-2023 measles outbreak demonstrates the potential of environmental surveillance to support measles elimination
Nkosenhle Ndlovu, Victor Mabasa, Chenoa Sankar, Nosihle Msomi, Emmanuel Phalane, Natasha Singh, Sipho Gwala, Fiona Els, Mokgaetji Macheke, Sibonginkosi Maposa, Mukhlid Yousif, Kerrigan M. McCarthy
medRxiv 2024.09.01.24312904; doi: https://doi.org/10.1101/2024.09.01.24312904
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Wastewater testing during the South African 2022-2023 measles outbreak demonstrates the potential of environmental surveillance to support measles elimination
Nkosenhle Ndlovu, Victor Mabasa, Chenoa Sankar, Nosihle Msomi, Emmanuel Phalane, Natasha Singh, Sipho Gwala, Fiona Els, Mokgaetji Macheke, Sibonginkosi Maposa, Mukhlid Yousif, Kerrigan M. McCarthy
medRxiv 2024.09.01.24312904; doi: https://doi.org/10.1101/2024.09.01.24312904

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)